Click for best price
Glaucoma Pharmaceuticals Market Size, Share 2023
| Market size in 2022 |
US$ 3349.7 million
|
Forecast Market size by 2029 |
US$ 3750.6 million
|
| Growth Rate |
CAGR of 1.6% |
Number of Pages |
71 Pages |
Glaucoma is caused due to rise in the intraocular pressure, if persists may lead to permanent eye damage.This increased pressure damages the optic nerve which transmits message to the brain High pressure is built due to the blockage of the trabecular meshwork which results in the accumulation of aqueous humor. Depending on the size of trabecular meshwork blockage, glaucoma can be categorized as open angle and narrow closure glaucoma. In open angle glaucoma trabecular meshwork blockage is wider than narrow angle glaucoma. This disease results in various symptoms such as redness in eye, nausea, vomiting, narrowing in vision and pain. This disease can be diagnosed by measuring eye pressure through tonometry.
This report aims to provide a comprehensive presentation of the global market for Glaucoma Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glaucoma Pharmaceuticals. This report contains market size and forecasts of Glaucoma Pharmaceuticals in global, including the following market information:
Global Glaucoma Pharmaceuticals Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Glaucoma Pharmaceuticals Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Glaucoma Pharmaceuticals companies in 2022 (%)
The global Glaucoma Pharmaceuticals market was valued at US$ 3349.7 million in 2022 and is projected to reach US$ 3750.6 million by 2029, at a CAGR of 1.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key growth drivers of the market include rising ageing population, healthcare expenditures, medical coverage and new innovative combination drugs. The market players in medication as well as devices segments are totally different and somewhat very fragmented.
We surveyed the Glaucoma Pharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glaucoma Pharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glaucoma Pharmaceuticals Market Segment Percentages, by Type, 2022 (%)
Prostaglandins Analogues (PGAs)
Non PGAs
Global Glaucoma Pharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glaucoma Pharmaceuticals Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
Global Glaucoma Pharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glaucoma Pharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glaucoma Pharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Glaucoma Pharmaceuticals revenues share in global market, 2022 (%)
Key companies Glaucoma Pharmaceuticals sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Glaucoma Pharmaceuticals sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acadia Pharmaceuticals Inc.
Allergan Inc.
Inotek Pharmaceuticals Corporation
Merck & Co. Inc.
Santen Pharmaceutical Co.Ltd.
Novartis International AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glaucoma Pharmaceuticals, market overview.
Chapter 2: Global Glaucoma Pharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of Glaucoma Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glaucoma Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Glaucoma Pharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Glaucoma Pharmaceuticals Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 3349.7 million
|
| Forecast Market size by 2029 |
US$ 3750.6 million
|
| Growth Rate |
CAGR of 1.6% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Glaucoma Pharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glaucoma Pharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glaucoma Pharmaceuticals Overall Market Size
2.1 Global Glaucoma Pharmaceuticals Market Size: 2022 VS 2029
2.2 Global Glaucoma Pharmaceuticals Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Glaucoma Pharmaceuticals Sales: 2018-2029
3 Company Landscape
3.1 Top Glaucoma Pharmaceuticals Players in Global Market
3.2 Top Global Glaucoma Pharmaceuticals Companies Ranked by Revenue
3.3 Global Glaucoma Pharmaceuticals Revenue by Companies
3.4 Global Glaucoma Pharmaceuticals Sales by Companies
3.5 Global Glaucoma Pharmaceuticals Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Glaucoma Pharmaceuticals Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Glaucoma Pharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glaucoma Pharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 Glaucoma Pharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 Glaucoma Pharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Glaucoma Pharmaceuticals Market Size Markets, 2022 & 2029
4.1.2 Prostaglandins Analogues (PGAs)
4.1.3 Non PGAs
4.2 By Type - Global Glaucoma Pharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Glaucoma Pharmaceuticals Revenue, 2018-2023
4.2.2 By Type - Global Glaucoma Pharmaceuticals Revenue, 2024-2029
4.2.3 By Type - Global Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
4.3 By Type - Global Glaucoma Pharmaceuticals Sales & Forecasts
4.3.1 By Type - Global Glaucoma Pharmaceuticals Sales, 2018-2023
4.3.2 By Type - Global Glaucoma Pharmaceuticals Sales, 2024-2029
4.3.3 By Type - Global Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
4.4 By Type - Global Glaucoma Pharmaceuticals Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Glaucoma Pharmaceuticals Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Private Clinics
5.1.4 Drug Stores
5.1.5 Retail Pharmacies
5.1.6 E-Commerce
5.2 By Application - Global Glaucoma Pharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Glaucoma Pharmaceuticals Revenue, 2018-2023
5.2.2 By Application - Global Glaucoma Pharmaceuticals Revenue, 2024-2029
5.2.3 By Application - Global Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
5.3 By Application - Global Glaucoma Pharmaceuticals Sales & Forecasts
5.3.1 By Application - Global Glaucoma Pharmaceuticals Sales, 2018-2023
5.3.2 By Application - Global Glaucoma Pharmaceuticals Sales, 2024-2029
5.3.3 By Application - Global Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
5.4 By Application - Global Glaucoma Pharmaceuticals Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Glaucoma Pharmaceuticals Market Size, 2022 & 2029
6.2 By Region - Global Glaucoma Pharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Glaucoma Pharmaceuticals Revenue, 2018-2023
6.2.2 By Region - Global Glaucoma Pharmaceuticals Revenue, 2024-2029
6.2.3 By Region - Global Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
6.3 By Region - Global Glaucoma Pharmaceuticals Sales & Forecasts
6.3.1 By Region - Global Glaucoma Pharmaceuticals Sales, 2018-2023
6.3.2 By Region - Global Glaucoma Pharmaceuticals Sales, 2024-2029
6.3.3 By Region - Global Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Glaucoma Pharmaceuticals Revenue, 2018-2029
6.4.2 By Country - North America Glaucoma Pharmaceuticals Sales, 2018-2029
6.4.3 US Glaucoma Pharmaceuticals Market Size, 2018-2029
6.4.4 Canada Glaucoma Pharmaceuticals Market Size, 2018-2029
6.4.5 Mexico Glaucoma Pharmaceuticals Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Glaucoma Pharmaceuticals Revenue, 2018-2029
6.5.2 By Country - Europe Glaucoma Pharmaceuticals Sales, 2018-2029
6.5.3 Germany Glaucoma Pharmaceuticals Market Size, 2018-2029
6.5.4 France Glaucoma Pharmaceuticals Market Size, 2018-2029
6.5.5 U.K. Glaucoma Pharmaceuticals Market Size, 2018-2029
6.5.6 Italy Glaucoma Pharmaceuticals Market Size, 2018-2029
6.5.7 Russia Glaucoma Pharmaceuticals Market Size, 2018-2029
6.5.8 Nordic Countries Glaucoma Pharmaceuticals Market Size, 2018-2029
6.5.9 Benelux Glaucoma Pharmaceuticals Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Glaucoma Pharmaceuticals Revenue, 2018-2029
6.6.2 By Region - Asia Glaucoma Pharmaceuticals Sales, 2018-2029
6.6.3 China Glaucoma Pharmaceuticals Market Size, 2018-2029
6.6.4 Japan Glaucoma Pharmaceuticals Market Size, 2018-2029
6.6.5 South Korea Glaucoma Pharmaceuticals Market Size, 2018-2029
6.6.6 Southeast Asia Glaucoma Pharmaceuticals Market Size, 2018-2029
6.6.7 India Glaucoma Pharmaceuticals Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Glaucoma Pharmaceuticals Revenue, 2018-2029
6.7.2 By Country - South America Glaucoma Pharmaceuticals Sales, 2018-2029
6.7.3 Brazil Glaucoma Pharmaceuticals Market Size, 2018-2029
6.7.4 Argentina Glaucoma Pharmaceuticals Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Glaucoma Pharmaceuticals Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Glaucoma Pharmaceuticals Sales, 2018-2029
6.8.3 Turkey Glaucoma Pharmaceuticals Market Size, 2018-2029
6.8.4 Israel Glaucoma Pharmaceuticals Market Size, 2018-2029
6.8.5 Saudi Arabia Glaucoma Pharmaceuticals Market Size, 2018-2029
6.8.6 UAE Glaucoma Pharmaceuticals Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Acadia Pharmaceuticals Inc.
7.1.1 Acadia Pharmaceuticals Inc. Company Summary
7.1.2 Acadia Pharmaceuticals Inc. Business Overview
7.1.3 Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Major Product Offerings
7.1.4 Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Sales and Revenue in Global (2018-2023)
7.1.5 Acadia Pharmaceuticals Inc. Key News & Latest Developments
7.2 Allergan Inc.
7.2.1 Allergan Inc. Company Summary
7.2.2 Allergan Inc. Business Overview
7.2.3 Allergan Inc. Glaucoma Pharmaceuticals Major Product Offerings
7.2.4 Allergan Inc. Glaucoma Pharmaceuticals Sales and Revenue in Global (2018-2023)
7.2.5 Allergan Inc. Key News & Latest Developments
7.3 Inotek Pharmaceuticals Corporation
7.3.1 Inotek Pharmaceuticals Corporation Company Summary
7.3.2 Inotek Pharmaceuticals Corporation Business Overview
7.3.3 Inotek Pharmaceuticals Corporation Glaucoma Pharmaceuticals Major Product Offerings
7.3.4 Inotek Pharmaceuticals Corporation Glaucoma Pharmaceuticals Sales and Revenue in Global (2018-2023)
7.3.5 Inotek Pharmaceuticals Corporation Key News & Latest Developments
7.4 Merck & Co. Inc.
7.4.1 Merck & Co. Inc. Company Summary
7.4.2 Merck & Co. Inc. Business Overview
7.4.3 Merck & Co. Inc. Glaucoma Pharmaceuticals Major Product Offerings
7.4.4 Merck & Co. Inc. Glaucoma Pharmaceuticals Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co. Inc. Key News & Latest Developments
7.5 Santen Pharmaceutical Co.Ltd.
7.5.1 Santen Pharmaceutical Co.Ltd. Company Summary
7.5.2 Santen Pharmaceutical Co.Ltd. Business Overview
7.5.3 Santen Pharmaceutical Co.Ltd. Glaucoma Pharmaceuticals Major Product Offerings
7.5.4 Santen Pharmaceutical Co.Ltd. Glaucoma Pharmaceuticals Sales and Revenue in Global (2018-2023)
7.5.5 Santen Pharmaceutical Co.Ltd. Key News & Latest Developments
7.6 Novartis International AG
7.6.1 Novartis International AG Company Summary
7.6.2 Novartis International AG Business Overview
7.6.3 Novartis International AG Glaucoma Pharmaceuticals Major Product Offerings
7.6.4 Novartis International AG Glaucoma Pharmaceuticals Sales and Revenue in Global (2018-2023)
7.6.5 Novartis International AG Key News & Latest Developments
8 Global Glaucoma Pharmaceuticals Production Capacity, Analysis
8.1 Global Glaucoma Pharmaceuticals Production Capacity, 2018-2029
8.2 Glaucoma Pharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global Glaucoma Pharmaceuticals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Glaucoma Pharmaceuticals Supply Chain Analysis
10.1 Glaucoma Pharmaceuticals Industry Value Chain
10.2 Glaucoma Pharmaceuticals Upstream Market
10.3 Glaucoma Pharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glaucoma Pharmaceuticals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Glaucoma Pharmaceuticals in Global Market
Table 2. Top Glaucoma Pharmaceuticals Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Glaucoma Pharmaceuticals Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Glaucoma Pharmaceuticals Revenue Share by Companies, 2018-2023
Table 5. Global Glaucoma Pharmaceuticals Sales by Companies, (K Units), 2018-2023
Table 6. Global Glaucoma Pharmaceuticals Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Glaucoma Pharmaceuticals Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Glaucoma Pharmaceuticals Product Type
Table 9. List of Global Tier 1 Glaucoma Pharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glaucoma Pharmaceuticals Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Glaucoma Pharmaceuticals Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Glaucoma Pharmaceuticals Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Glaucoma Pharmaceuticals Sales (K Units), 2018-2023
Table 15. By Type - Global Glaucoma Pharmaceuticals Sales (K Units), 2024-2029
Table 16. By Application ? Global Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Glaucoma Pharmaceuticals Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Glaucoma Pharmaceuticals Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Glaucoma Pharmaceuticals Sales (K Units), 2018-2023
Table 20. By Application - Global Glaucoma Pharmaceuticals Sales (K Units), 2024-2029
Table 21. By Region ? Global Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Glaucoma Pharmaceuticals Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Glaucoma Pharmaceuticals Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Glaucoma Pharmaceuticals Sales (K Units), 2018-2023
Table 25. By Region - Global Glaucoma Pharmaceuticals Sales (K Units), 2024-2029
Table 26. By Country - North America Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Glaucoma Pharmaceuticals Sales, (K Units), 2018-2023
Table 29. By Country - North America Glaucoma Pharmaceuticals Sales, (K Units), 2024-2029
Table 30. By Country - Europe Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Glaucoma Pharmaceuticals Sales, (K Units), 2018-2023
Table 33. By Country - Europe Glaucoma Pharmaceuticals Sales, (K Units), 2024-2029
Table 34. By Region - Asia Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Glaucoma Pharmaceuticals Sales, (K Units), 2018-2023
Table 37. By Region - Asia Glaucoma Pharmaceuticals Sales, (K Units), 2024-2029
Table 38. By Country - South America Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Glaucoma Pharmaceuticals Sales, (K Units), 2018-2023
Table 41. By Country - South America Glaucoma Pharmaceuticals Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Glaucoma Pharmaceuticals Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Glaucoma Pharmaceuticals Sales, (K Units), 2024-2029
Table 46. Acadia Pharmaceuticals Inc. Company Summary
Table 47. Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Product Offerings
Table 48. Acadia Pharmaceuticals Inc. Glaucoma Pharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Acadia Pharmaceuticals Inc. Key News & Latest Developments
Table 50. Allergan Inc. Company Summary
Table 51. Allergan Inc. Glaucoma Pharmaceuticals Product Offerings
Table 52. Allergan Inc. Glaucoma Pharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Allergan Inc. Key News & Latest Developments
Table 54. Inotek Pharmaceuticals Corporation Company Summary
Table 55. Inotek Pharmaceuticals Corporation Glaucoma Pharmaceuticals Product Offerings
Table 56. Inotek Pharmaceuticals Corporation Glaucoma Pharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Inotek Pharmaceuticals Corporation Key News & Latest Developments
Table 58. Merck & Co. Inc. Company Summary
Table 59. Merck & Co. Inc. Glaucoma Pharmaceuticals Product Offerings
Table 60. Merck & Co. Inc. Glaucoma Pharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Merck & Co. Inc. Key News & Latest Developments
Table 62. Santen Pharmaceutical Co.Ltd. Company Summary
Table 63. Santen Pharmaceutical Co.Ltd. Glaucoma Pharmaceuticals Product Offerings
Table 64. Santen Pharmaceutical Co.Ltd. Glaucoma Pharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Santen Pharmaceutical Co.Ltd. Key News & Latest Developments
Table 66. Novartis International AG Company Summary
Table 67. Novartis International AG Glaucoma Pharmaceuticals Product Offerings
Table 68. Novartis International AG Glaucoma Pharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Novartis International AG Key News & Latest Developments
Table 70. Glaucoma Pharmaceuticals Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 71. Global Glaucoma Pharmaceuticals Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Glaucoma Pharmaceuticals Production by Region, 2018-2023 (K Units)
Table 73. Global Glaucoma Pharmaceuticals Production by Region, 2024-2029 (K Units)
Table 74. Glaucoma Pharmaceuticals Market Opportunities & Trends in Global Market
Table 75. Glaucoma Pharmaceuticals Market Drivers in Global Market
Table 76. Glaucoma Pharmaceuticals Market Restraints in Global Market
Table 77. Glaucoma Pharmaceuticals Raw Materials
Table 78. Glaucoma Pharmaceuticals Raw Materials Suppliers in Global Market
Table 79. Typical Glaucoma Pharmaceuticals Downstream
Table 80. Glaucoma Pharmaceuticals Downstream Clients in Global Market
Table 81. Glaucoma Pharmaceuticals Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Glaucoma Pharmaceuticals Segment by Type in 2022
Figure 2. Glaucoma Pharmaceuticals Segment by Application in 2022
Figure 3. Global Glaucoma Pharmaceuticals Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Glaucoma Pharmaceuticals Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Glaucoma Pharmaceuticals Revenue, 2018-2029 (US$, Mn)
Figure 7. Glaucoma Pharmaceuticals Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glaucoma Pharmaceuticals Revenue in 2022
Figure 9. By Type - Global Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
Figure 11. By Type - Global Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
Figure 12. By Type - Global Glaucoma Pharmaceuticals Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
Figure 15. By Application - Global Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
Figure 16. By Application - Global Glaucoma Pharmaceuticals Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Glaucoma Pharmaceuticals Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
Figure 20. By Region - Global Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
Figure 21. By Country - North America Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
Figure 22. By Country - North America Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
Figure 23. US Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
Figure 28. Germany Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 29. France Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
Figure 37. China Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 41. India Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
Figure 43. By Country - South America Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
Figure 44. Brazil Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Glaucoma Pharmaceuticals Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Glaucoma Pharmaceuticals Sales Market Share, 2018-2029
Figure 48. Turkey Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Glaucoma Pharmaceuticals Revenue, (US$, Mn), 2018-2029
Figure 52. Global Glaucoma Pharmaceuticals Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Glaucoma Pharmaceuticals by Region, 2022 VS 2029
Figure 54. Glaucoma Pharmaceuticals Industry Value Chain
Figure 55. Marketing Channels
